期刊文献+

宫颈鳞癌中肺癌肿瘤阻抑基因-1和上皮型钙黏蛋白的定量研究 被引量:5

Expression of TSLC1 and E-cadherin in cervical squamous carcinoma by quantitative study
暂未订购
导出
摘要 目的探讨肺癌肿瘤阻抑基因-1(TSLC1)、上皮型钙黏蛋白(E-cad)在宫颈鳞癌组织芯片中的表达及其临床意义,并分析两者的相关性。方法应用免疫组化法和图像分析技术分别对29例宫颈鳞癌组织、20例CINs、10例正常宫颈组织TSLC1、E-cad的含量进行研究。结果TSLC1、E-cad在正常宫颈及CINⅠ级组织中,多呈强阳性表达,CINⅡ级以上及宫颈鳞癌组织表达呈递减趋势,差异有显著性(P<0.05)。宫颈鳞癌组织中TSLC1蛋白表达失活与淋巴转移有关,差异有显著性(t=4.558,P=0.000);与组织病理分级无关(P>0.05)。E-cad蛋白表达失活与组织病理学分级和淋巴转移有关,差异有显著性(P<0.05)。TSLC1蛋白、E-cad蛋白表达呈正相关(r=0.678,P=0.000)。结论组织芯片是大规模平行检测多基因蛋白表达的一种方法;TSLC1、E-cad蛋白表达失活使其丧失了抑癌作用,是促使正常宫颈上皮细胞癌变的一个重要因素。 [Objective] To detect the expression of TSLC1 and E-cad in cervical cancer by tissue microarray and to evaluate their clinical significance and correlation between the two genes. [Methods] 59 specimens of tissues, including squamous carcinoma of the cervix, CINs and normal tissues underwent microarray examination and immuno- histochenmistry to detect the expression of TSLC1, E-cad. The intensity of TSLC1 and E-cad protein were investigated by analyzing with imaging technique. [Results] The result showed that the expression of strong positive cell in normal cervical tissue and CIN Ⅰ were significantly higher than those of CIN Ⅱ, CIN Ⅲ and squamous carcinoma of the cervix. There was no association between TSLC1 expression and histological type. But the expression of TSLC1 was significantly correlated with lymphatic metastasis. Inactivation of E-cad gene expression in cervical cancer was significantly related to do with lymphatic metastasis and histological type. The expression of TSLC1 and E-cad in cervical tissue were positive correlated (r=0.678, P=0.000). [Conclusion] Tissue microarray technique is effective method to detect multiple gene protein expression. Inactivation of TSLC1, E-cad gene expression is an important factor in the uterine cervical carcinogenesis.
出处 《中国现代医学杂志》 CAS CSCD 北大核心 2008年第13期1801-1803,1809,共4页 China Journal of Modern Medicine
关键词 TSLC1 E-CAD 组织芯片 免疫组化定量分析 宫颈鳞癌 TSLC1 E-cad tissue microarray quantitative study squamous carcinoma of the cervix
  • 相关文献

参考文献2

二级参考文献101

  • 1邢学森,黄利鸣,黄益玲,陈梅花,石新兰.改良的甲基化特异PCR法在人宫颈癌Hela细胞检测中的应用[J].中国现代医学杂志,2006,16(2):191-194. 被引量:6
  • 2[1]Tamura G,Kihana T,Nomura K,Terada M,Sugimura T,Hirohashi S.Detection of frequent p53 gene mutations in primary gastric cancer by cell sorting and polymerase chain reaction single-strand conformation polymorphism analysis.Cancer Res 1991; 51:3056-3058
  • 3[2]Becker KF,Atkinson MJ,Reich U,Becker I,Nekarda H,Siewert JR,Hofler H.E-cadherin gene mutations provide clues to diffuse type gastric carcinomas.Cancer Res 1994; 54:3845-3852
  • 4[3]Tamura G,Sakata K,Nishizuka S,Maesawa C,Suzuki Y,Iwaya T,Terashima M,Saito K,Satodate R.Inactivation of the E-cadherin gene in primary gastric carcinomas and gastric carcinoma cell lines.Jpn J Cancer Res 1996; 87:1153-1159
  • 5[4]Kim IJ,Kang HC,Shin Y,Park HW,Jang SG,Han SY,Lim SK,Lee MR,Chang HJ,Ku JL,Yang HK,Park JG.A TP53-truncating germline mutation (E287X) in a family with characteristics of both hereditary diffuse gastric cancer and LiFraumeni syndrome.J Hum Genet 2004; 49:591-595
  • 6[5]Guilford P,Hopkins J,Harraway J,McLeod M,McLeod N,Harawira P,Taite H,Scoular R,Miller A,Reeve AE.E-cadherin germline mutations in familial gastric cancer.Nature 1998; 392:402-405
  • 7[6]Tamura G,Yin J,Wang S,Fleisher AS,Zou T,Abraham JM,Kong D,Smolinski KN,Wilson KT,James SP,Silverberg SG,Nishizuka S,Terashima M,Motoyama T,Meltzer SJ.E-Cadherin gene promoter hypermethylation in primary human gastric carcinomas.JNatl Cancer Inst 2000; 92:569-573
  • 8[7]Nishizuka S,Tamura G,Terashima M,Satodate R.Loss of heterozygosity during development and progression of differentiated adenocarcinoma of the stomach.J Pathol 1998;185:3843
  • 9[8]Akiyama Y,Nakasaki H,Nihei Z,Iwama T,Nomizu T,Utsunomiya J,Yuasa Y.Frequent microsatellite instabilities and analyses of the related genes in familial gastric cancers.Jpn J Cancer Res 1996; 87:595-601
  • 10[9]Semba S,Yokozaki H,Yasui W,Tahara E.Frequent microsatellite instability and loss of heterozygosity in the region including BRCA1 (17q21) in young patients with gastric cancer.Int J Oncol 1998; 12:1245-1251

共引文献114

同被引文献90

  • 1许良中,杨文涛.免疫组织化学反应结果的判断标准[J].中国癌症杂志,1996,6(4):229-231. 被引量:1380
  • 2中华病理学杂志编辑委员会.《全国免疫组织化学技术与诊断标准化专题研讨会》会议纪要[J].中华病理学杂志,1996,25(6):326-328.
  • 3Pisani P, Bray F, Parkin D M. Estimates of the worldwide prevalence of cancer for 25 sites in the adult population[J]. Int J Cancer, 2002,97: 72-81.
  • 4Jones P. A, Baylin S. B. The epigenomics of cancer[J].Cell 2007,128(4) :683-692.
  • 5Ting A H,McGarvey K M,Baylin S B,et al. The cancer epigenome components and functional correlates[J]. Genes Dev, 2006,20(23) : 3215-3231.
  • 6Brueckner B, Kuck D, Lyko F, et al. DNA methyltransferase inhibitors for cancer therapy[J]. Cancer J, 2007,13 (1):17-22.
  • 7Egger G, Liang G, Aparicio A, et al. Epigenetics in human disease and prospects for epigenetie therapy [J]. Nature, 2004,429(6990):457-463.
  • 8Overmeer R M, Henken F E,Snijders P J ,et al. Association between dense CADM1 promoter methylation and reduced protein expression in high-grade CIN and cervical SCC[J]. Pathol,2008,215(4) :388-397.
  • 9Ehrich M, Nelson M R, Stanssens P, et al. Quantitative high-throughput analysis of DNA methylation patterns by base-specific cleavage and mass spectrometry[J]. PNAS, 2005,102(44) :15785-15790.
  • 10Lukaszuk K,Liss J,Wozniak I, et al. Human papillomavirus type 16 status in cervical carcinoma cell DNA assayed by multiplex PCR [J]. J Clin Microbiol, 2003,41 (2) :608-612.

引证文献5

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部